ms. brandt. to me opioid manufacturers through twisted research, deceptive marketing and bought and paid for patient advocacy groups had a significant role in fueling the crisis. now, you are going to be the point person for the trump team. do you share those kind of concerns that i mentioned? >> the -- i am doing everything and the department is doing everything we can to limit opioid prescriptions now to only when opioid prescriptions are important to the patient. we are supporting non-opioid uses. we are supporting alternative care. so absolutely i agree with you that opioid prescribing needs to be decreased, we need better science, better information, a key pillar of what we're doing is trying to decrease the unnecessary opioids. again, i do mean this respectfully. how we got here and who was responsible i think is a matter for the committee and others to ascertain. >> i want you to have the chance to respond in writing. >> yes, sir. >> because i don't think we got here by just well meaning p